Stefano Gobbo

Papers

1

Total Citations

121

H-Index

1

About

Stefano Gobbo is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for pancreatic cancer treatment, with a particular emphasis on improving oncological outcomes and patient recovery. His most impactful contribution is the landmark DIPLOMA trial (2023), an international randomised non-inferiority study that compared minimally invasive distal pancreatectomy (MIDP) with open surgery for resectable pancreatic cancer. This work, cited over 120 times, provided critical evidence addressing longstanding concerns about the oncological safety of minimally invasive approaches in pancreatic surgery, demonstrating that MIDP can achieve comparable outcomes to open procedures when performed by experienced surgeons. Gobbo's research has helped reshape clinical practice by validating minimally invasive techniques for carefully selected pancreatic cancer patients, potentially reducing hospital stays and postoperative complications without compromising cancer clearance. His work sits at the intersection of surgical innovation and rigorous evidence-based medicine, making him a key figure in the ongoing evolution of pancreatic cancer surgery. Through the DIPLOMA trial and related studies, Gobbo has established himself as a researcher committed to answering fundamental questions about surgical safety and efficacy in one of the most challenging areas of oncologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
121
Total Citations
121
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial
121 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 91

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago